September 21, 2022Letter Agreement • September 26th, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
This letter agreement (this “Agreement”) is being delivered to MediWound Ltd., a company organized under the laws of the State of Israel (the “Company”) in connection with that certain Securities Purchase Agreement, dated as of the date hereof, by and among the Company and the investors signatory thereto (the “Purchase Agreement”) by the undersigned shareholders of the Company (each, a “Shareholder” and collectively, the “Shareholders”). Certain capitalized terms used herein are defined in Section 11 hereof. Capitalized terms used but not otherwise defined herein have the respective meanings ascribed to such terms in the Purchase Agreement.
MEDIWOUND LTD. PIGGY-BACK RIGHTS WAIVERRights Waiver • September 26th, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
Reference is made to the Amended & Restated Registration Rights Agreement (the “A&R Registration Rights Agreement”), dated as of April 6, 2021, by and among MediWound Ltd. (the “Company”) and the shareholders of the Company listed on Schedule A thereto (the “Shareholders”). All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the A&R Registration Rights Agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • September 26th, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
